{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:13:19Z","timestamp":1777533199129,"version":"3.51.4"},"reference-count":37,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.radonc.2009.08.045","type":"journal-article","created":{"date-parts":[[2009,9,25]],"date-time":"2009-09-25T16:31:57Z","timestamp":1253896317000},"page":"492-497","source":"Crossref","is-referenced-by-count":18,"title":["A randomized phase II study of CEOP with or without semustine as induction chemotherapy in patients with stage IE\/IIE extranodal NK\/T-cell lymphoma, nasal type in the upper aerodigestive tract"],"prefix":"10.1016","volume":"93","author":[{"given":"Xuejun","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ye","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqiang","family":"Pang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Biyun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongfen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya-Jia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaomao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2009.08.045_bib1","series-title":"World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues.","first-page":"204","article-title":"Extranodal NK\/T-cell lymphoma, nasal type","author":"Chan JKC","year":"2001"},{"key":"10.1016\/j.radonc.2009.08.045_bib2","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/(SICI)1097-0142(19980815)83:4<806::AID-CNCR26>3.3.CO;2-8","volume":"83","author":"Ko","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2009.08.045_bib3","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1093\/annonc\/mdi037","article-title":"Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years","volume":"16","author":"Au","year":"2005","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2009.08.045_bib4","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1093\/annonc\/mdn147","article-title":"Clinical heterogeneity of extranodal NK\/T-cell lymphoma, nasal type: a national survey of the Korean Cancer Study Group","volume":"19","author":"Kim","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2009.08.045_bib5","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1016\/j.ejca.2005.03.010","article-title":"Extranodal nasal type NK\/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy","volume":"41","author":"Lee","year":"2005","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2009.08.045_bib6","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1182\/blood-2003-05-1401","article-title":"Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index","volume":"103","author":"Chim","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2009.08.045_bib7","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin\u2019s lymphoma","volume":"339","author":"Miller","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2009.08.045_bib8","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1056\/NEJMoa042040","article-title":"ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma","volume":"352","author":"Reyes","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2009.08.045_bib9","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1200\/JCO.2005.03.2573","article-title":"Radiotherapy as primary treatment for stage IE and IIE nasal natural killer\/T-cell lymphoma","volume":"24","author":"Li","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2009.08.045_bib10","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0360-3016(02)02916-4","article-title":"Early stage nasal NK\/T-cell lymphoma: clinical outcome, prognostic factors, and the effect of treatment modality","volume":"54","author":"Cheung","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2009.08.045_bib11","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin\u2019s lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2009.08.045_bib12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1054\/bjoc.2000.1566","article-title":"Survival in patients with intermediate or high grade non-Hodgkin\u2019s lymphoma: meta-analysis of randomized studies comparing third generation regimens with CHOP","volume":"84","author":"Messori","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2009.08.045_bib13","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijrobp.2007.05.073","article-title":"Early or up-front radiotherapy improved survival of localized extranodal NK\/T-cell lymphoma, nasal-type in the upper aerodigestive tract","volume":"70","author":"Huang","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2009.08.045_bib14","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1023\/A:1011144911781","article-title":"CHOP followed by involved field radiation: is it optimal for localized nasal natural killer\/T-cell lymphoma?","volume":"12","author":"Kim","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2009.08.045_bib15","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1038\/sj.bjc.6602502","article-title":"Nasal-type NK\/T cell lymphoma: clinical features and treatment outcome","volume":"92","author":"Lee","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2009.08.045_bib16","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000225162","article-title":"Results with CCNU in resistant Hodgkin\u2019s and non-Hodgkin\u2019s lymphoma","volume":"33","author":"Stolinsky","year":"1976","journal-title":"Oncology"},{"key":"10.1016\/j.radonc.2009.08.045_bib17","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/1097-0142(197805)41:5<1658::AID-CNCR2820410502>3.0.CO;2-I","article-title":"Comparison of methyl-CCNU and CCNU in patients with advanced forms of Hodgkin\u2019s disease, lymphosarcoma nad reticulum cell sarcoma","volume":"41","author":"Maurice","year":"1978","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2009.08.045_bib18","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/0959-8049(93)90171-B","article-title":"Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphoma","volume":"29A","author":"Sweetenham","year":"1993","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2009.08.045_bib19","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/cncr.21024","article-title":"Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma","volume":"103","author":"Musolino","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2009.08.045_bib20","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.oraloncology.2006.11.020","article-title":"Combined chemoradiation for the management of nasal natural killer (NK)\/T-cell lymphoma: elucidating the significance of systemic chemotherapy","volume":"44","author":"Guo","year":"2008","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2009.08.045_bib21","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","article-title":"Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI sponsored international working group","volume":"17","author":"Cheson","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2009.08.045_bib22","doi-asserted-by":"crossref","first-page":"3785","DOI":"10.1182\/blood-2005-05-2056","article-title":"Local tumor invasiveness is more predictive of survival than international prognostic index in stage I(E)\/II(E) extranodal NK\/T-cell lymphoma, nasal type","volume":"106","author":"Kim","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2009.08.045_bib23","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1200\/JCO.2004.06.088","article-title":"Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin\u2019s lymphoma: Eastern Cooperative Oncology Group study 1484","volume":"22","author":"Horning","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2009.08.045_bib24","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1182\/blood.V81.9.2215.2215","article-title":"Clinical significance of P-glycoprotein in multidrug resistance malignancies","volume":"81","author":"Arceci","year":"1993","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2009.08.045_bib25","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/0006-2952(94)90209-7","article-title":"Expression and function of multidrug resistance P-glycoprotein in a cultured natural killer cell-rich population revealed by MRK16 monoclonal antibody and AHC-52","volume":"48","author":"Kobayashi","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.radonc.2009.08.045_bib26","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.1182\/blood.V89.8.2966","article-title":"CD3- CD56+ non-Hodgkin\u2019s lymphomas with an aggressive behavior related to multidrug resistance","volume":"89","author":"Drenou","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2009.08.045_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1182\/blood.V93.2.599","article-title":"P-glycoprotein expression on normal and abnormally expanded natural killer cells and inhibition of P-glycoprotein function by cyclosporin A and its analogue, PSC833","volume":"93","author":"Egashira","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2009.08.045_bib28","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1002\/1097-0142(19951201)76:11<2351::AID-CNCR2820761125>3.0.CO;2-1","article-title":"Frequent expression of P-glycoprotein\/MDR1 by nasal T-cell lymphoma cells","volume":"76","author":"Yamaguchi","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2009.08.045_bib29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1046\/j.1440-1827.2001.01214.x","article-title":"Epstein-Barr virus infection, drug resistance and prognosis in Korean T- and NK-cell lymphomas","volume":"51","author":"Jung","year":"2001","journal-title":"Pathol Int"},{"key":"10.1016\/j.radonc.2009.08.045_bib30","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1080\/10428190410001693524","article-title":"Lack of correlation between P-glycoprotein and chemotherapy resistance in nasal NK\/T-cell lymphomas","volume":"45","author":"Kim","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.radonc.2009.08.045_bib31","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ajh.21256","article-title":"Immunohistochemical expression and clinical significance of P-glycoprotein in previously untreated extranodal NK\/T-cell lymphoma, nasal type","volume":"83","author":"Wang","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.radonc.2009.08.045_bib32","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1080\/10428190600562823","article-title":"First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +\/\u2212 radiotherapy is active in stage I\/II extranodal NK\/T-cell lymphoma","volume":"47","author":"Lee","year":"2006","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.radonc.2009.08.045_bib33","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1200\/JCO.20.1.197","article-title":"Brief chemotherapy and involved-region irradiation for limited-stage diffuse large-cell lymphoma: an 18-year experience from the British Columbia Cancer Agency","volume":"20","author":"Shenkier","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2009.08.045_bib34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1148\/radiology.204.2.9240537","article-title":"Clinical stage IE primary lymphoma of the nasal cavity: radiation therapy and chemotherapy","volume":"204","author":"Shikama","year":"1997","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2009.08.045_bib35","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.ijrobp.2003.12.006","article-title":"Angiocentric T-cell and NK\/T-cell lymphomas: radiotherapeutic viewpoints","volume":"59","author":"Koom","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2009.08.045_bib36","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/cncr.11908","article-title":"Treatment outcome and pattern of failure in 77 patients with sinonasal natural killer\/T-cell or T-cell lymphoma","volume":"100","author":"Li","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2009.08.045_bib37","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1002\/cncr.21656","article-title":"Extranodal natural killer\/T-cell lymphoma, nasal type: the significance of radiotherapeutic parameters","volume":"106","author":"Isobe","year":"2006","journal-title":"Cancer"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814009004976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814009004976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T13:30:22Z","timestamp":1590154222000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814009004976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":37,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0167814009004976"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2009.08.045","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}